# Deferasirox

NDC: 72205-389
Generic name: Deferasirox
Labeler / Manufacturer: Novadoz Pharmaceuticals LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, FOR SUSPENSION
Routes: ORAL
Marketing started: 20191120

FDA application: ANDA209878

## Active ingredients

- DEFERASIROX: 125 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"72205-389"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=72205-389
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a03c7657-fdca-4acb-ad82-c24680e90eae